Global Antihypertensive Drug Market by Drug Category (Diuretics, ACE inhibitors, Angiotensin converting enzyme, Alpha blockers, Beta blockers, Renin inhibitors, Calcium channel blockers and others), Distribution Channel (Hospital, e-commerce, Retail pharmacy) and Region (North America, Europe, Asia-pacific, LAMEA): Global Forecasts 2017 to 2027 Research Report by AllTheResearch.
The global antihypertensive drug market was valued at USD 29.7 billion in 2020, and it is expected to reach USD 34.1 billion by 2027, with a CAGR of 2.1%, during the forecast period (2021-2027).
Increase in number of cardiovascular diseases, rising stress level, diabetes patients, change in lifestyle pattern are the factors responsible for the growth of antihypertensive drugs Industry.
Request a Sample Report- https://www.alltheresearch.com/sample-request/445
Hypertension is a long-term diseased condition which requires continue medication and regular follow-ups from the medical practitioner. It is the condition when there is elevated blood pressure in arteries, which concise of high blood pressure. Antihypertensive drugs are used to control the blood pressure to normal. Hypertension give rise to many other life-threatening complications like sever heart attack, dementia, heart failure and apparently shows effects on renal system also. Research proves that decrease in blood pressure by 5mmHg can reduce the stroke risk by about 34%, heart disease by 21% and limits the chances of dementia and mortality of cardiovascular diseases. The classification of antihypertensive drugs works on different parameters. Drugs are broadly classified on the basis of their route of action like diuretics, calcium channel blockers, ace inhibitors, beta-blockers, combination alpha-beta blockers etc. Out of all classes, ACE inhibitors stood to be best tolerant antihypertensive drug which is the most widely used in patients suffering from hypertension. From class of diuretics, Thiazide drug is considered to be the choice of treatment for the patients which reduces the mortality and morbidity rate.
The factors that drive the growth of antihypertensive drug market are the changing life style of people, consumption of junk food, smoking, alcohol, improper diet, insomnia due to stress are the condition which contribute in increase in number of hypertension patients and leaves to increase in demand for antihypertensive drugs. Once the patient is diagnosed with such condition, there is regular demand for consumption of antihypertensive drugs, and this enhances the demand for medication and act as driving factor for the anti-hypertensive drugs market.
Several governments and companies are collaborating and conducting various campaigns associated with the hypertension drive. One of the is “Know your numbers” is the campaign which was intended to celebrate World hypertension day on 17th May by World Health Organization for the purpose of spreading awareness regarding regular check-up of blood pressure. Another campaign initiated by SERVIER which was conducted in collaboration with International Society of Hypertension, to make public aware about hypertension and its treatment. The emergence of new drug moiety for the treatment of hypertension is invented with the combination of three most potent drugs namely Telmisartan, Amlodipine and Chlorthalidone. These are collectively called as ‘Triple pill’. Use of combination drug therapy provides high protection to the organ as compared with single drug therapy. This new trend of combination therapy proves to be more effective and widely used across the world. Antihypertensive drug market is still believed to be alive and growing as there are lot of opportunities available for new entrants in the antihypertensive drug market.
Key Findings:
- Based on Drug category, calcium channel blockersegment held a significant share of the global antihypertensive drugs market in 2020 and this is expected to continue during the forecast period 2021 to 2027. This can be attributed to high tolerance to geriatric patients.
- Based on distribution channel, the hospitals segment occupied the largest share of the antihypertensive drugs market. This can be attributed to presence of large patient pool.
- Geographically, North America is accounted for the largest share and is expected to witness the significant growth during the forecast period. However, Asia Pacific is expected to observe the fastest growth of antihypertensive drug market during the forecast period.
Recent News of Antihypertensive Drug Market
- In August 2020, according to new study led by researchers at Columbia University Irving Medical Center, Chlorthalidone causes more serious side effects than hydrochlorothiazide while lowering blood pressure.
- In August 2020, according to several published studies medication use for the treatment of high blood pressure may increase the Covid-19 survival rates, and decreases the severity of coronavirus infection, specially in hypertension patients.
Read More Information- https://www.alltheresearch.com/report/445/global-antihypertensive-drug-market
About Us
AllTheResearch was formed with the aim of making market research a significant tool for managing breakthroughs in the industry. As a leading market research provider, the firm empowers its global clients with business-critical research solutions. The outcome of our study of numerous companies that rely on market research and consulting data for their decision-making made us realize, that it's not just sheer data points, but the right analysis that creates a difference. While some clients were unhappy with the inconsistencies and inaccuracies of data, others expressed concerns over the experience in dealing with the research-firm. Also, same-data-for-all-business roles were making research redundant. We identified these gaps and built AllTheResearch to raise the standards of research support.
For All Your Research Needs, Reach Out to Us:
Contact Name: Rohan S.
Email: [email protected]
Phone: +1 (407) 768-2028
Antihypertensive Drugs Market is observing random and spectacular growth at a high CAGR in forthcoming period.
Moreover, change in lifestyle habits such as smoking, diet and exercising also contribute to hypertension, thus adding to the market growth.
Top Key Manufacturers of Antihypertensive Drugs market are :-NovartisPfizerJohnson & JohnsonSanofiLupinOther Antihypertensive Drugs Market by Product Type:ARBCCBOther Antihypertensive Drugs Market by Applications:HypertensionPAHOther Geographical Analysis of Antihypertensive Drugs Market:- North AmericaEuropeChinaJapanSoutheast AsiaIndia Primary hyper tension is more prevalent than secondary hypertension whereas primary hypertension has no underlying causes; secondary hypertension is caused by kidney, heart, endocrine or arterial disorders.
The systolic pressure is in the range of 120-140Hg at rest and in the range of 60-90 mm diastolic.
Hypertension could also lead to aggravation of other diseases that lead to cardiac arrests and increasing mortality.
Based on therapeutics, the Antihypertensive drugs market is classified into diuretics, angiotenism converting inhibitors (ACE), Angiotensin receptor blockers (ARE), angiotensin receptor blockers, calcium channel blockers, beta blockers, alpha blockers, vasodilators and rennin inhibitors.
Global Heparin Market by Product (Low Molecular Weight Heparin (LMWH), Ultra-low Molecular Weight Heparin (ULMWH)), by Application (Venous Thromboembolism, Coronary Artery Disease, Atrial Fibrillation, Others), by Distribution Channel (Hospital Pharmacies, Drug Stores & Retail Pharmacies, Online Pharmacies) by Route of Administration (Intravenous, Subcutaneous), and by Region (North America, Europe, Asia Pacific, Latin America, MEA), - Global Forecasts 2017 to 2027 Research Report by AllTheResearch.The Global Heparin Market was valued at USD 6.5 billion in 2020 and is expected to reach USD 9.7 billion by 2027, growing at a CAGR of 5.9% during the forecast period, 2021 - 2027.Rapid Rise in medical emergencies is leading to high demand for Heparin after the Covid 19 impact.Heparin doses are often used to treat a wide range of health problems such as deep vein thrombosis, acute coronary syndrome, atrial fibrillation, pulmonary embolism, and even cardiopulmonary bypass and hemofiltration during cardiac surgery, this extravagant usage is propelling the market growth.
In addition, the supply of synthetic and semi-synthetic heparin mimetics that help treat cancer, coagulation, and inflammatory diseases is expected to provide a favorable opportunity for heparin adoption.Request a Sample Report- https://www.alltheresearch.com/sample-request/514 The Global Heparin Market Segmentation:The global heparin market is segmented into product, application, distribution channel, route of administration, and region.By Product TypeLow Molecular Weight Heparin (LMWH)Ultra-low Molecular Weight Heparin (ULMWH)By ApplicationVenous ThromboembolismCoronary Artery DiseaseAtrial FibrillationOthersBy Distribution ChannelHospital PharmaciesDrug Stores & Retail PharmaciesOnline PharmaciesBy Route of AdministrationIntravenousSubcutaneousBy RegionNorth AmericaEuropeAsia PacificLatin AmericaMiddle East & AfricaThe report provides with an in-depth analysis of market trends, financial analysis, segmentation analysis, company profiles, recent news and much more.
On the basis of applications, the coronary artery disease segment is accounted to dominate the market, owing to the increase in prevalence of heart- related disorders n past few years.Geographically, the North American region is dominating the market with highest revenue.
Report also covers analysis of some of the key players including Fresenius SE & Co KGaA, B. Braun Holding GmbH & Co. KG, Baxter International Inc., Dr. Reddy’s Laboratories Ltd., and Aspen Holdings among others.
Read More Information- https://www.alltheresearch.com/report/514/heparin-market-market Global Heparin Market Report Highlights.Based on distribution channel, the hospital pharmacies segment accounted for the highest share in 2020 which is accounted to the easy access and patients’ trust.By route of administration, the subcutaneous segment registered for the largest share in the market in 2020.
The growth is attributed to low cost associated with hospitalization compared to others.Despite of the economic slowdown in the past few years due to the COVID-19 crisis, the heparin market is witnessing the upsurge owing to the increased cases of respiratory diseases in the COVID-19 outbreak.Recent NewsBraun Holding GmbH & Co. KG in June 2021 has announced a acquisition over Nutrichem, in order to strengthen the market base for B. Braun Holding Gmbh & Co. KG in the enteral nutrition and clinical nutrition fields.In September 2019, the Baxter International Inc. announced its successful acquisition over Cheetah Medical, a company which provides non-invasive hemodynamic monitoring technologies.
AllTheResearch recently updated their research study on Industry 4.0 Market based on Corporate Strategy Analysis by leading players like General Electric Co., Cognex Corporation, Siemens AG, Daifuku, Honeywell International, ABB Ltd., Intel Corporation, Emerson Electric, etc., Investment Landscape, Type, Application.
The report covers Leading Countries and analyzes the potential of the global Industry 4.0 industry, providing statistical information about market dynamics, growth factors, major challenges, PEST analysis, and market entry strategy Analysis, opportunities, and forecasts.
The biggest highlight of the report is to provide companies in the industry with a strategic analysis of the impact of COVID-19.
The Industry 4.0 Market size was valued at US$ 81.7 Bn in 2020 and is expected to grow at a compound annual growth rate (CAGR) of 20.3% for the forecast period ending 2027 reaching a Market value of US$ 298.1 Bn.
Research Objective Industry 4.0 Market Research:To analyze and forecast the market size of the global Industry 4.0 market.To classify and forecast the global Industry 4.0 market based on the product, power type.To identify drivers and challenges for the global Industry 4.0 market.To examine competitive developments such as mergers & acquisitions, agreements, collaborations, and partnerships, etc., in the global Industry 4.0 market.To conduct pricing analysis for the global Industry 4.0 market.To identify and analyze the profile of leading players operating in the global Industry 4.0 market.The Major Companies Covered in Industry 4.0 Market Report are:General Electric Co.Cognex CorporationSiemens AGDaifukuHoneywell InternationalInternational Business Machines CorporationABB Ltd.Intel CorporationEmerson ElectricJohn Bean Technologies Corporation3D SystemsNvidia CorporationMicrosoft CorporationMitsubishi Electric CorporationAlphabet Inc.Techman RobotCisco Systems, Inc.Schneider Electric SEThe Yaskawa Electric CorporationSwisslog Holding AG (Kuka AG)Universal RobotsBeckhoff AutomationAddverb TechnologiesBigchainDB GmbHAIBrainFor the competitor segment, the report includes global key players of Industry 4.0 as well as some small players.The information for each competitor includes:Company ProfileMain Business InformationSWOT AnalysisSales, Revenue, Price and Gross MarginMarket ShareApplication Analysis: Global Industry 4.0 market also specifically underpins end-use application scope and their improvements based on technological developments and consumer preferences.Aerospace and DefenseOil and GasElectronics and FoundryManufacturingFood and BeverageAutomotiveEnergy and UtilitiesOtherProduct Type Analysis: Global Industry 4.0 market also specifically underpins type scope and their improvements based on technological developments and consumer preferences.AI and MLExtended RealityIndustrial Robotics3D PrintingIndustrial IoTDigital TwinBlockchainMachine Condition MonitoringOthers (Industrial Sensor, HMI, Machine Vision)Regional Analysis of Industry 4.0 Market:From a geographic segmentation perspective, the report focuses on the regions that have a material and significant effect on the overall market value.
The broad level coverage of the report includes the regions and key countries within the regions of Global, North America, Europe, APAC, MEAImpact of COVID-19 on Industry 4.0 Market:The report also contains the effect of the ongoing worldwide pandemic, i.e., COVID-19, on the Industry 4.0 Market and what the future holds for it.
The Business Research Company’s latest report Drug Delivery Devices Global Market Report 2020 covers Drug Delivery Devices market drivers, Drug Delivery Devices market trends, Drug Delivery Devices market segments, Drug Delivery Devices market growth rate, Drug Delivery Devices market major players, and Drug Delivery Devices market size.
The report provides in-depth analysis of the impact of COVID-19 on the Drug Delivery Devices industry, along with revised market numbers due to the effects of the coronavirus.
View Complete Report:https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-market-global-report-2020-2030-covid-19-implications-and-growthDrug Delivery Devices Global Market Report 2020 is the most comprehensive report available on this market and will help gain a truly global perspective as it covers 60 geographies.
The chapter on the impact of COVID-19 gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market.
The chapter also covers markets which have been positively affected by the pandemic.Request for the sample now:https://www.thebusinessresearchcompany.com/sample.aspx?id=2833=smpThe global drug delivery devices market is expected to grow from $1.4 billion in 2019 to about $1.6 billion in 2020 as there is a marginal increase in demand due to the use of such devices in the treatment of COVID-19 patients.
The market is expected to stabilize and reach $1.9 billion at a CAGR of 8.2% through 2023.The report covers the Drug Delivery Devices market’s segments- 1) By Route Of Administration: Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery2) By Patient Care Setting: Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Home Care Settings, Others3) By Application: Cancer, Infectious Diseases, Respiratory Diseases, Diabetes, Cardiovascular Diseases, Autoimmune Diseases, Central Nervous System Disorders, Others.About The Business Research Company:The Business Research Company is a Business Intelligence Company which excels in company, market and consumer research.
